Myeloproliferative Neoplasms

Doctor And Nurse Suture Patient In Emergency Room

Transplant Trends in Patients with Myelofibrosis

A study published in Transplant and Cellular Therapy assessed outcomes in patients with myelofibrosis (MF) who choose to under hematopoietic cell transplant (HCT) versus...
vile filled with blood laying on a piece of paper that says "Myeloproliferative neoplasms"

Decitabine Plus Ruxolitinib Demonstrates Clinical Benefit in Patients with MPN

Decitabine with or without ruxolitinib is beneficial for patients with advanced myeloproliferative neoplasms (MPN) when initiated early in the disease course prior to the...
The senior man gestures while telling the visiting nurse about his symptoms. They are sitting in his living room.

Does Race Impact Survival in Patients with Philadelphia Chromosome-Negative MPN?

A study published in Hematology/Oncology and Stem Cell Therapy observed no significant difference in the rate of thrombotic or hemorrhagic events between white and...

Fedratinib Safe for Long-Term Treatment of Myelofibrosis

A study presented as part of the ASH 2020 Annual Meeting found that use of fedratinib for 24 or more weeks was well-tolerated in...

Interferon-Alpha Prevents Myelofibrosis and Extends Survival in Patients with Polycythemia Vera

Interferon-alpha (rIFNα) is the only disease-modifying treatment option for polycythemia vera (PV). A study published in Leukemia found that treatment of PV with rIFNα...

Patterns of Ruxolitinib Use in Older Patients with Myelofibrosis

The Janus kinase (JAK) inhibitor ruxolitinib was U.S. Food and Drug Administration-approved for patients with high-risk myelofibrosis (MF) in 2011. Researchers sought to assess...

Study Finds Imetelstat Improves Myelofibrosis Survival in JAK-Refractory Patients

A study presented as part of the ASH 2020 Annual Meeting found that imetelstat improved overall survival (OS) in patients with myelofibrosis (MF) who...
Advertisement

Journal Reading List

Advertisement
Advertisement